IP Library Granted Patent US 10,287,276
Granted Patent B2
US 10,287,276 · App. 15/556,722 · Granted May 14, 2019

Heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds for controlling ectoparasites

Inventors: Paolo Tosatti (Binningen, CH); Jean-Yves Wach (Zurich, CH)
Assignee: Elanco Tiergesundheit AG
C07D405/14A61P33/14C07D401/04C07D401/14C07D403/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,287,276
App. No.
15/556,722
Granted
May 14, 2019
Kind
B2
Abstract

The present invention provides compounds of the formula: (I) wherein: X is O or S; Q 1 and Q 2 are independently CR 5 or N, provided at least one of Q 1 and Q 2 is N; Y is a direct bond or CH 2 ; R 1 is H, optionally substituted alkyl, alkenyl, alkynyl, cycloalkylalkyl, benzyl or oxetan-3-yl-CH 2 —; R 2 is optionally substituted phenyl, pyridine, pyrimidine, pyrazine or pyridazine; R 3 is alkyl or haloalkyl; R 4 is optionally substituted pyridine, pyrimidine, pyrazine or pyridazine; R 5 is H, alkyl, haloalkyl, cycloalkyl, alkoxy, alkoxyC(O)— or (alkoxy) 2 CH—; or a salt thereof. The compounds are useful for controlling ectoparasites on animals.

Claims (103)

1. A compound of the formula

wherein:

X is O or S;

Q 1 and Q 2 are independently CR 5 or N, provided at least one of Q 1 and Q 2 is N;

Y is a direct bond or CH 2 ;

R 1 is H; C 1 -C 6 alkyl optionally substituted with one substituent selected from: CN, CONH 2 , COOH, NO 2 and —Si(CH 3 ) 3 ; C 1 -C 6 haloalkyl; C 2 -C 6 alkenyl; C 2 -C 6 haloalkenyl; C 2 -C 6 alkynyl; C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkyl-C 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 —; or benzyl optionally substituted with halo or C 1 -C 3 haloalkyl;

R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon bonded to the

 group, each independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halo, NO 2 , SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ;

R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl;

R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one substituent selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, C 3 -C 4 cycloalkyl, halo or hydroxy; and

R 5 is H, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 alkoxyC(O)— or (C 1 -C 3 alkoxy) 2 CH—;

or a salt thereof.

2. The compound or salt according to claim 1 , wherein Y is a direct bond.

3. The compound or salt according to claim 1 , wherein X is O.

4. The compound or salt according to claim 1 , wherein R 3 is methyl.

5. The compound or salt according to claim 1 , wherein Q 1 is N, Q 2 is CR 5 , and R 5 is H, methyl, or (CH 3 CH 2 O) 2 CH—.

6. The compound or salt according to claim 1 , wherein R 4 is 2-pyridine, or 2-pyrimidine optionally substituted by C 1 -C 3 alkoxy.

7. The compound or salt according to claim 6 , wherein R 4 is 2-pyrimidine.

8. The compound or salt according to claim 1 , wherein R 1 is cyclopropyl-CH 2 —, n-propyl, CH≡C—CH 2 —, CF 3 CH 2 CH 2 —, FCH 2 CH 2 —, FCH 2 CH 2 CH 2 —, 2,2-difluorocyclopropyl-CH 2 —, 2,2-dichlorocyclopropyl-CH 2 —, H, CH 3 , (CH 3 ) 3 SiCH 2 —, CH 3 CH 2 — or CNCH 2 —.

9. The compound or salt according to claim 8 , wherein R 1 is cyclopropyl-CH 2 —, CH≡C—CH 2 —, H or CH 3 .

10. The compound or salt according to claim 1 , wherein R 2 is 3,5-bis(trifluoromethyl)phenyl, 3,5-dichlorophenyl, 3-trifluoromethoxyphenyl, 3-chloro-5-trifluoromethylphenyl, 3-cyanophenyl, 3-chloro-5-trifluoromethoxyphenyl, 5-trifluoromethylpyridin-3-yl, 3-bromo-5-trifluoromethylphenyl, 3-cyano-5-trifluoromethylphenyl or 2,6-bis(trifluoromethyl)pyridin-4-yl.

11. The compound or salt according to claim 10 , wherein R 2 is 3,5-bis(trifluoromethyl)phenyl.

12. A formulation comprising a compound or salt according to claim 1 , and at least one acceptable carrier.

13. A method of controlling ectoparasites on an animal in need thereof comprising administering an effective amount of the compound or salt according to claim 1 .

14. The compound or salt according to claim 1 , which is:

N-(Cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

3,5-Dichloro-N-(cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]benzamide;

3,5-Dichloro-N-propyl-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]benzamide;

N-(Cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3-(trifluoromethoxy)benzamide;

N-[(3-Chlorophenyl)methyl]-3-cyano-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]benzamide;

3-Chloro-N-(cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethyl)benzamide;

3-Chloro-N-prop-2-ynyl-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethyl)benzamide;

3-Chloro-N-propyl-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethyl)pyridine-3-carboxamide;

3-Chloro-N-(cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethoxy)benzamide;

N-(2-Fluoroethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[1-[2-(2-Pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-b is (trifluoromethyl)-N-(3,3,3-trifluoropropyl)benzamide;

N-(Oxetan-3-ylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-(Cyanomethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-Prop-2-ynyl-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[(2,2-Difluorocyclopropyl)methyl]-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[(2,2-Dichlorocyclopropyl)methyl]-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Chloro-N-prop-2-ynyl-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-5-(trifluoromethoxy)benzamide;

N-(2-Fluoroethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)-N-(3,3,3-trifluoropropyl)benzamide;

N-(3-Fluoropropyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Chloro-N-(2-fluoroethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethoxy)benzamide;

3-Chloro-N-(2-fluoroethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Chloro-N-(3-fluoropropyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Chloro-N-(3-fluoropropyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethoxy)benzamide;

3-Chloro-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)-N-(3,3,3-trifluoropropyl)benzamide;

3-Chloro-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethoxy)-N-(3,3,3-trifluoropropyl)benzamide;

N-(Cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-[1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)-N-(3,3,3-trifluoropropyl)pyridine-3-carboxamide;

N-(2-Fluoroethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-(3-Fluoropropyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-Prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-(Cyclopropylmethyl)-N-[1-(1-pyrimidin-2-yltetrazol-5-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Cyano-N-(cyclopropylmethyl)-N-[1-[5-methyl-2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]benzamide;

N-Prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Chloro-N-prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethoxy)-benzamide;

3-chloro-N-(cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethoxy)benzamide;

3-Cyano-N-(cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]benzamide;

N-(Cyclopropylmethyl)-N-[1-[2-(5-methoxypyrimidin-2-yl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Chloro-N-(cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Chloro-N-prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-[2-[2-(2-pyridyl)-1,2,4-triazol-3-yl]propyl]-3,5-bis(trifluoromethyl)benzamide;

N-Prop-2-ynyl-N-[(1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-(Cyclopropylmethyl)-N-R1S)-1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-R1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoro methyl)pyridine-3-carboxamide;

N-Prop-2-ynyl-N-[(1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Cyano-N-(cyclopropylmethyl)-N-[1-[2-(2-pyridyl)-1,2,4-triazol-3-yl]ethyl]benzenecarbothioamide;

N-(Cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-R1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Cyano-N-(cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2,6-bis(trifluoromethyl)pyridine-4-carboxamide;

3-Cyano-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]benzamide;

N-Ethyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Cyano-N-prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]benzamide;

3-Cyano-N-methyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]benzamide;

N-(Cyanomethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Cyano-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Cyano-N-prop-2-ynyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Cyano-N-ethyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

3-Cyano-N-methyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-[1-(5-methyl-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

3-Bromo-N-(cyclopropylmethyl)-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

N-[1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-R1S)-1-[2-(5-fluoropyrimidin-2-yl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-Methyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[(1S)-1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)-N-(trimethylsilylmethyl)benzamide;

3-Cyano-N-R1S)-1-[2-(5-fluoropyrimidin-2-yl)-1,2,4-triazol-3-yl]ethyl]benzamide;

N-R1S)-1-[2-(5-Fluoropyrimidin-2-yl)-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

N-(Cyclopropylmethyl)-N-R1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)bent enecarbothioamide;

3-Carbamothioyl-N-methyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]benzamide;

3-Carbamothioyl-N-methyl-N-[1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-5-(trifluoromethyl)benzamide;

N-[1-[5-(Diethoxymethyl)-2-pyrimidin-2-yl-1,2,4-triazol-3-yl]ethyl]-3,5-bis(trifluoromethyl)benzamide;

Methyl5-[1-[[3,5-bis(trifluoromethyl)benzoyl]amino]ethyl]-1-pyrimidin-2-yl-1,2,4-triazole-3-carboxylate; or

N-Methyl-N-R1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide.

15. The compound or salt according to claim 1 , which is N-(cyclopropylmethyl)-N-[(1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide, N-Prop-2-ynyl-N-[(1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-b is (trifluoromethyl)benzamide or N-methyl-N-[(1S)-1-(2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide.

16. A compound that is N-R1S)-1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide or a salt thereof.

17. A compound that is N-[(1S)-1-(2-Pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-3,5-bis(trifluoromethyl)benzamide.

Assignments (3)
CHANGE OF NAME Recorded Sep 27, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 044027/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2017
From: TOSATTI, PAOLO; WACH, JEAN-YVES
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 043531/0508 →
CHANGE OF NAME Recorded Sep 8, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043791/0640 →
Continuity (2)
Provisional Application 62332004 · May 5, 2016
Related Publication 20180186778A1 · Jul 5, 2018
Cited By (1)
US 12,583,851